Sionna cuts nearly half of staff as it lines up second attempt at cystic fibrosis

Data ReadoutnegativeNegative

AI Analysis

Summary

Sionna Therapeutics announced a 46% staff reduction following an unexpected trial failure in its cystic fibrosis program. The company is seeking to reposition its strategy following the setback.

Clinical Trial Data

Primary Endpoint

Not Met

Outcome Details

unexpected trial failure in cystic fibrosis

Importance:5/10

Sentiment:

-0.80

layoffstrial failurecystic fibrosisrestructuring

Read the original article

Published by Endpoints News on September 15, 2026 3:34 PM

Read Original